Text

Expression Protein p53 Mutation in Non-Small-Cell Lung Carcinoma

---

Introduction. The tumor supressor gen p53 mutation encodes a protein that inhibits programmed cell death (apoptosis). The protein is expressed in basal cells in normal human epithelium, but no data are available on the frequency or clinical importance of its expression in carcinoma. We studied p53 mutation protein expression in post surgery tissues of patients with non-small cell lung carcinoma (NSCLC) and evaluated the correlation between protein expressions with prognosis of diseases.
Methods. We have performed a retrospective study using 43 parafin block samples of NSCLC patients who were underwent surgery in Persahabatan Hospital during 1997 to 2008. The p53 mutation protein expression were analyzed by immunohystochemical method using a monoclonal antibody specificfor p53 mutation protein. The possibility that p53 mutation expression correlated with survival was investigated with the log-rank test Kaplan Meier.
Results. Patients characteristic we found male 25/43 (58,1%) female 18/43 (41,9%) with mean age 56,19 ± 8,3 y.o and mostly age 40 to 60 y.o 33/43 (76,7%). Number of smoker patiens were 31/43 (72,1%) We also detected p53 mutation protein in 16/43 (37,2%) in NSCLC tissues. Regarding histopatology types were 9/18 (500 in squamous-cell carcinomas and 7/25 (28%) in adenocarcinomas. The corellation between positive
3 mutation protein expressions with pathological staging was significant p 0,004, according to T status T1- T2 62,5% and T3-T4 23,8% have had positive p53 mutation protein. Favorable prognostic significance of p53 mutation in patients with NSCLC stage 1- 11, patients in the positive p53 mutataion survived longer than those in negative with respective median survival durations 28 and 18 months p 0,019. Adenocarcinomas type with p53 mutation median survival 11 months compared with squamous-cell carcinomas 14 months.
Conclusion. Gene p53 mutation protein found in NSCLC tissues and seems to have role in early stage of lung carcinogenesis. Prognostic significance in stage 1- 11.
Keywords: p53 mutation protein, apoptosis, immunohystochemia, NSCLC, prognosis.

---

Availability

Detail Information

Series Title

-

Call Number

Jurnal Respirologi Indonesia31(3)2010:134-145

Publisher

Jakarta : Perhimpunan Dokter Paru Indonesia., 2010

Collation

11p.

Language

ISBN/ISSN

0853-7704

Classification

-

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

lung neoplasms
proteins
GENES, P53

Specific Detail Info

-

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment